Monitoring and Management of Skin Lesions

Clinical Evaluation and Follow-up

• The American Academy of Pediatrics recommends clinical monitoring of halo nevi with regular follow-up, and biopsy only if concerning features are present, such as color variation, nodules, or symptoms suggesting malignant transformation 1
• A thorough visual inspection, palpation, and dermoscopic evaluation of the halo nevus should be performed to assess for concerning features, including color variation, nodules, symptoms, and ulceration 1
• Patients with halo nevi should be instructed to self-examine the lesion and report concerning changes between visits 1

Referral and Specialized Care

• Consider referral to dermatology for specialized care, especially for patients with multiple halo nevi or atypical features, with more frequent follow-up (every 3 months) 1
• A full thickness excisional biopsy with a 2 mm margin of normal skin is recommended for proper diagnosis and management of a mole, according to the British Journal of Dermatology guidelines 2, 3
• Orient the excision to facilitate possible subsequent wide local excision (along the long axis on limbs), and avoid shave biopsies for suspicious pigmented lesions, as suggested by the British Journal of Dermatology 3

Diagnostic Procedures

• The pathology report should include maximum tumor thickness (Breslow), level of invasion (Clark levels I-V), clearance of surgical margins, presence of ulceration, and presence and extent of regression, as recommended by the Annals of Oncology 2
• The pathology report for melanocytic lesions should include confirmation of melanocytic origin, architectural pattern and cellular characteristics, presence/absence of melanocytic hyperplasia or clear cell activity, and margin status, according to the British Journal of Cancer 4

2, 3

Management of Confirmed Melanoma

• For confirmed melanoma, wide excision with 1-2 cm margins based on tumor thickness, evaluation for regional lymph node involvement, and staging workup including imaging studies for patients with higher stage disease is recommended, as supported by the Journal of the American Academy of Dermatology 5 and the National Comprehensive Cancer Network 6
• Sentinel node biopsy should be performed to stage clinically negative regional nodes, as recommended by the National Comprehensive Cancer Network guidelines 6

Follow-up and Surveillance

• Follow-up schedules vary by stage: in situ melanoma (no follow-up), Stage IA melanoma (2-4 visits over 12 months), and Stage IB-IIIA melanoma (every 3 months for 3 years, then every 6 months to 5 years), as suggested by the British Journal of Dermatology 3
• More frequent follow-up (every 3-6 months) and documentation with clinical photographs for lesions with concerning features is recommended, as suggested by the Annals of Oncology 7

Prevention and Education

• Teach self-examination techniques to patients with multiple moles or atypical moles, provide education about concerning changes, consider total body photography for monitoring, and recommend sun protection measures, as recommended by the British Journal of Dermatology 3
• Evaluate for risk factors, including giant congenital melanocytic nevi, multiple medium-sized CMN or ≥10 "satellite" lesions, family history of melanoma, previous melanoma history, and atypical mole syndrome, as identified by the American Academy of Pediatrics 1 and the British Association of Dermatologists 3
• UV radiation exposure, including sun exposure and tanning beds, increases the risk of skin cancer, as reported by JAMA 8
• Family history of skin cancer and having more than 50 moles also increase the risk of skin cancer, according to the Annals of Internal Medicine 9
• High-risk individuals require increased vigilance, as reported by 10